Algo version: 0.98b
AKRO is listed at the NASDAQ Exchange
AKRO [AKRO]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is AKRO stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Akero Therapeutics Inc 10 years ago, but if you had invested on Thursday 20th of June 2019 when the price was $18.32, you would have made a profit of $8.09 per share or 44.16%

Yes, the average daily trading liquidity for Akero Therapeutics Inc is $16.43 million. You should therefore be able to get in and out of your positions relatively fast.

Akero Therapeutics Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Akero Therapeutics Inc to be medium [0.7 out of 1]